Ostra białaczka szpikowa
Charakterystyka, pielęgnacja i opieka

Ostra białaczka szpikowa (AML) to agresywny nowotwór hematologiczny, stanowiący około 80% ostrych białaczek u dorosłych, ze średnim wiekiem zachorowania 67-68 lat i 5-letnią przeżywalnością na poziomie 28-30%. Choroba charakteryzuje się niekontrolowaną proliferacją niedojrzałych mieloblastów w szpiku kostnym, prowadząc do pancytopenii, immunosupresji i ryzyka powikłań infekcyjnych oraz krwotocznych. Typowe objawy to anemia, gorączka, krwawienia, przerost dziąseł i bóle kostne. Diagnostyka i monitorowanie obejmują ocenę morfologii krwi, rozmazu, objawów infekcji i krwawień oraz ocenę psychospołeczną pacjenta. Kluczowe diagnozy pielęgniarskie to ryzyko infekcji, ryzyko urazu z powodu małopłytkowości, zmęczenie, niedobór objętości płynów oraz zaburzenia obrazu ciała.

Ostra białaczka szpikowa (AML) – wprowadzenie

Ostra białaczka szpikowa (AML), znana również jako ostra białaczka mieloblastyczna lub mielocytowa, jest najczęstszym typem ostrej białaczki u dorosłych, stanowiąc około 80% wszystkich przypadków białaczek u osób dorosłych12. Jest to szybko rozwijający się nowotwór szpiku kostnego i krwi, charakteryzujący się niekontrolowaną proliferacją mieloblastów i hiperplazją szpiku kostnego3. Komórki, które powinny przekształcić się w prawidłowe białe krwinki, nie dojrzewają całkowicie i nie są zdolne do walki z infekcjami4.

AML jest chorobą starszych dorosłych, ze średnim wiekiem zachorowania wynoszącym 67-68 lat56. Pięcioletnia przeżywalność wynosi około 28-30%76. Ze względu na agresywny charakter choroby, leczenie powinno rozpocząć się jak najszybciej po postawieniu diagnozy8.

Objawy i ocena stanu pacjenta z AML

Pacjenci z AML doświadczają szeregu objawów wynikających z niewydolności szpiku kostnego i nieskutecznej erytropoezy. Do typowych objawów należą: zmęczenie, osłabienie, owrzodzenia jamy ustnej, bóle głowy, krwawienia, gorączka, anemia i przerost dziąseł3. Innymi częstymi objawami są nawracające infekcje, łatwe siniaczenie, nadmierne krwawienie i bóle kostne1.

W ramach procesu diagnostycznego i oceny stanu pacjenta pielęgniarka powinna przeprowadzić kompleksową ocenę, która obejmuje:

  • Monitorowanie morfologii krwi i rozmazu – obserwacja oznak zwiększonego ryzyka infekcji (neutropenia), anemii i małopłytkowości9
  • Ocenę objawów infekcji – gorączka, dreszcze i wszelkie nowe objawy powinny być natychmiast zgłaszane, ponieważ pacjenci z białaczką są w stanie immunosupresji9
  • Ocenę krwawienia – poszukiwanie wybroczyn, siniaków i krwawienia z dziąseł, szczególnie u pacjentów z małopłytkowością9
  • Ocenę psychospołeczną – określenie mechanizmów radzenia sobie pacjenta, systemu wsparcia i potrzeby wsparcia psychologicznego9

Diagnozy pielęgniarskie w opiece nad pacjentem z AML

Zidentyfikowanie właściwych diagnoz pielęgniarskich jest kluczowym elementem opieki nad pacjentem z AML. Najczęstsze diagnozy pielęgniarskie obejmują:

Ryzyko infekcji związane z leukopenią i leczeniem immunosupresyjnym

Pacjenci z AML są szczególnie narażeni na infekcje z powodu wpływu choroby na szpik kostny i układ odpornościowy. Białaczka zaburza wytwarzanie prawidłowych komórek krwi, w tym białych krwinek, które odgrywają kluczową rolę w zwalczaniu infekcji, pozostawiając organizm podatnym na zakażenia bakteryjne, grzybicze i wirusowe10.

Ryzyko krwawienia związane z małopłytkowością i zahamowaniem czynności szpiku kostnego

Najbardziej odpowiednią diagnozą pielęgniarską dla pacjenta z ostrą białaczką szpikową i małopłytkowością (niską liczbą płytek krwi) jest ryzyko urazu11. Małopłytkowość naraża pacjenta na wysokie ryzyko krwawienia12.

Zmęczenie związane z anemią i skutkami chemioterapii

Pacjenci z AML często doświadczają zmęczenia spowodowanego anemią oraz skutkami ubocznymi leczenia chemioterapeutycznego13.

Ryzyko niedoboru objętości płynów

Pacjenci z białaczką są narażeni na niedobór objętości płynów z powodu kilku czynników, w tym nadmiernych strat przez wymioty, biegunkę lub krwawienie, zmniejszonego spożycia płynów z powodu słabego apetytu oraz zwiększonego zapotrzebowania na płyny wynikającego z gorączki lub chemioterapii14.

Zaburzenia obrazu ciała

Zaburzenia obrazu ciała związane z utratą włosów, utratą wagi i bladością skóry spowodowane leczeniem białaczki13.

Interwencje pielęgniarskie w opiece nad pacjentem z AML

Opieka pielęgniarska nad pacjentem z AML obejmuje szeroki zakres interwencji mających na celu wsparcie pacjenta podczas leczenia i minimalizację powikłań.

Zapobieganie infekcjom

Pacjenci z AML są szczególnie podatni na infekcje z powodu osłabionego układu odpornościowego. Kluczowe interwencje obejmują:

  • Wdrożenie środków ostrożności dla pacjentów z neutropenią, takich jak higiena rąk, ograniczenie odwiedzających i unikanie narażenia na czynniki zakaźne13
  • Edukacja pacjenta w zakresie profilaktyki infekcji poprzez mycie rąk, płukanie wszystkich owoców i warzyw, unikanie tłumów i szukanie pomocy przy pierwszych oznakach gorączki152
  • Podawanie antybiotyków zgodnie z zaleceniami. Antybiotyki mogą być stosowane profilaktycznie w celu zapobiegania infekcjom, szczególnie jeśli pacjent przechodzi inwazyjne procedury16
  • Zalecenie odpowiedniej izolacji – najodpowiedniejszym miejscem dla pacjenta z małopłytkowością poddawanego leczeniu ostrej białaczki limfoblastycznej jest sala prywatna, aby chronić go przed infekcjami, które mogłyby zostać przyniesione przez innych11

Środki ostrożności związane z krwawieniem

Ze względu na małopłytkowość konieczne jest podjęcie środków ostrożności w celu zapobiegania krwawieniom:

  • Edukacja pacjenta w zakresie unikania czynności, które mogą prowadzić do urazów, używania miękkich szczoteczek do zębów i unikania leków dostępnych bez recepty, takich jak aspiryna13
  • Unikanie ostrych przedmiotów. Używanie elektrycznej golarki do golenia. Używanie pilniczka do paznokci, aby utrzymać paznokcie krótkie i gładkie17
  • Dbanie o jamę ustną. Używanie miękkiej szczoteczki do zębów. Unikanie nitkowania zębów, gdy liczba płytek krwi jest niska. Unikanie wykałaczek17
  • Zapewnienie odpowiedniego wsparcia transfuzyjnego, w tym transfuzji płytek krwi i czynników krzepnięcia (świeżo mrożone osocze, krioprecypitat) zgodnie z wynikami badań krwi pacjenta i historią krwawień18

Opieka wspierająca

Opieka wspierająca jest kluczowym elementem leczenia pacjentów z AML:

  • Zapewnienie strategii oszczędzania energii w celu zarządzania zmęczeniem, takich jak częste okresy odpoczynku i małe, bogate w składniki odżywcze posiłki13
  • Monitorowanie parametrów laboratoryjnych i wyników badań diagnostycznych, które dostarczają cennych informacji dla planowania leczenia i zarządzania19
  • Skuteczne zarządzanie bólem jest niezbędne do złagodzenia cierpienia, poprawy jakości życia i zapewnienia komfortu pacjentowi14
  • Zapewnienie odpowiedniego odżywiania, które może pomóc wzmocnić układ odpornościowy pacjenta, zmniejszając ryzyko infekcji16

Wsparcie emocjonalne

Wsparcie emocjonalne jest istotną częścią opieki nad pacjentami z AML:

  • Oferowanie usług doradczych i zachęcanie do uczestnictwa w grupach wsparcia dla osób z białaczką13
  • Pomoc pacjentom w opracowywaniu strategii radzenia sobie i problemami z obrazem ciała, w tym radzeniem sobie z utratą włosów13
  • Zapewnienie ciągłego wsparcia emocjonalnego, które jest niezbędne dla pacjentów z białaczką3

Fazy leczenia AML i rola pielęgniarki

Leczenie AML zazwyczaj przebiega w dwóch głównych fazach: indukcji remisji i konsolidacji. Pielęgniarka odgrywa kluczową rolę w każdej z tych faz.

Terapia indukcyjna

Pierwsza faza leczenia AML ma na celu zniszczenie komórek białaczkowych we krwi i szpiku kostnym20. Terapia indukcyjna jest wysoce toksyczna dla szpiku kostnego, powodując pancytopenie i powikłania krwotoczne, problemy z układem pokarmowym, niewydolność nerek z powodu zespołu lizy guza i zaburzenia elektrolitowe15.

Rola pielęgniarki w terapii indukcyjnej obejmuje:

  • Administrowanie leków i monitorowanie potencjalnych powikłań2
  • Monitorowanie parametrów koagulacji, kontrolę parametrów życiowych, zapewnienie ochrony skóry, monitorowanie infekcji i sepsy2
  • Podawanie transfuzji czerwonych krwinek i płytek krwi w celu skorygowania anemii i zapobiegania krwawieniom21
  • Edukację pacjenta i rodziny w zakresie procesu leczenia i możliwych skutków ubocznych2

Terapia konsolidacyjna

Po osiągnięciu całkowitej remisji (CR) za pomocą terapii indukcyjnej, rozpoczyna się terapia konsolidacyjna z wysokimi dawkami cytarabiny, nazywana HiDAC, oraz przeszczepieniem komórek krwiotwórczych (HCT)15. Celem tej fazy jest zniszczenie pozostałych komórek białaczkowych22.

Rola pielęgniarki w terapii konsolidacyjnej obejmuje:

  • Monitorowanie pacjenta pod kątem skutków ubocznych intensywnej chemioterapii23
  • Wsparcie pacjenta podczas przygotowań do przeszczepu szpiku kostnego, jeśli jest to część planu leczenia24
  • Edukację pacjenta na temat zwiększonego ryzyka infekcji po przeszczepie24
  • Koordynację opieki między różnymi specjalistami w zespole interdyscyplinarnym25

Edukacja pacjenta i rodziny

Edukacja pacjenta i jego rodziny jest kluczowym elementem opieki pielęgniarskiej w AML. Obejmuje ona szereg tematów, które pozwalają pacjentowi i jego bliskim lepiej zrozumieć chorobę i aktywnie uczestniczyć w procesie leczenia.

Informacje o chorobie i leczeniu

Pielęgniarka powinna przekazać pacjentowi i jego rodzinie kompleksowe informacje na temat AML i dostępnych opcji leczenia:

  • Edukacja pacjenta i rodziny o znaczeniu zapobiegania infekcjom i o tym, jak rozpoznawać oznaki infekcji, takie jak gorączka26
  • Omówienie potencjalnych skutków ubocznych chemioterapii i terapii celowanych, w tym nudności, wypadania włosów i zwiększonego ryzyka krwawienia26
  • Dostarczenie informacji o przeszczepieniu komórek macierzystych, jeśli ma to zastosowanie, w tym o procesie i potencjalnych powikłaniach26
  • Zachęcanie opiekunów do zapewnienia wsparcia emocjonalnego i pomocy w codziennych potrzebach pacjenta, w tym transportu na leczenie i zapewnienia przestrzegania zaleceń dotyczących leków26

Wytyczne dotyczące samoopieki

Edukacja w zakresie samoopieki jest ważna dla pacjentów z AML i powinna obejmować następujące tematy:

  • Zapobieganie infekcjom: Częste mycie rąk, unikanie osób chorych i codzienne czyszczenie nawilżaczy27
  • Zapobieganie krwawieniom i siniaczeniu: Ostrożność z ostrymi lub spiczastymi przedmiotami, takimi jak noże i wykałaczki. Unikanie sportów kontaktowych. Używanie miękkiej szczoteczki do zębów27
  • Nawodnienie: Picie płynów zgodnie z zaleceniami. Może być konieczne picie dodatkowych płynów, aby zapobiec odwodnieniu, zwłaszcza w przypadku wymiotów lub biegunki spowodowanych leczeniem28
  • Aktywność fizyczna: Ćwiczenia zgodnie z zaleceniami. AML lub jego leczenie może powodować zmęczenie. Ćwiczenia mogą pomóc w zwiększeniu energii i kontroli wagi28
  • Zdrowe odżywianie: Zdrowe pokarmy mogą pomóc pacjentowi poczuć się lepiej i mieć więcej energii28

Opieka i obserwacja po leczeniu

Edukacja pacjenta powinna również obejmować informacje o opiece po zakończeniu leczenia:

  • Opieka po zakończeniu leczenia jest kluczowym elementem leczenia i bezpieczeństwa. Należy upewnić się, że pacjent umawia się i uczestniczy we wszystkich wizytach kontrolnych29
  • Przyjmowanie leków dokładnie zgodnie z zaleceniami. Zachęcanie pacjenta do kontaktu z lekarzem lub pielęgniarką w przypadku problemów z lekami29
  • Obserwacja zmian w stanie zdrowia i kontakt z lekarzem lub pielęgniarką, jeśli pacjent jest znacznie bardziej zmęczony niż zwykle, ma obrzęknięte węzły chłonne w pachach, pachwinie lub szyi, lub nie czuje się lepiej zgodnie z oczekiwaniami29
  • Pacjenci z białaczką powinni nadal spotykać się z zespołem ośrodka leczniczego i/lub lokalnym podstawowym lekarzem po zakończeniu leczenia30

Opieka interdyscyplinarna nad pacjentem z AML

AML to powszechna złośliwa choroba hematologiczna u dorosłych. Pomimo wielu postępów, nowotwór ten nadal wiąże się ze złym rokowaniem. Dlatego najlepiej jest nim zarządzać przez wielodyscyplinarny zespół, który obejmuje hematologa, onkologa, internistę, patologa i intensywistę2.

Rola zespołu opieki zdrowotnej

Kompleksowa opieka nad pacjentem z AML wymaga zaangażowania różnych specjalistów:

  • Hematolog/onkolog: Specjalista zajmujący się diagnozowaniem i leczeniem nowotworów krwi31
  • Pielęgniarka specjalizująca się w onkologii: Kluczowa dla podawania leczenia i monitorowania potencjalnych powikłań2
  • Farmaceuci: Specjalizujący się w lekach stosowanych w białaczce, znający ich toksyczność32
  • Specjaliści od przeszczepu szpiku kostnego: Kluczowi w przypadku pacjentów kwalifikujących się do przeszczepu33
  • Dietetycy, fizjoterapeuci, pracownicy socjalni i psycholodzy: Zapewniający kompleksowe wsparcie pacjenta34

Koordynacja opieki

Skuteczna koordynacja opieki ma kluczowe znaczenie dla optymalizacji wyników leczenia pacjentów z AML:

  • Koordynacja opieki dla pacjentów zdiagnozowanych z AML, szczególnie tych, którzy nie kwalifikują się do przeszczepu, może wpłynąć na dostęp do specjalistycznej opieki, badań klinicznych i programów onkologicznych o zaawansowanych możliwościach leczenia25
  • Pielęgniarki nawigacyjne pomagają w umawianiu wizyt, koordynowaniu wizyt kontrolnych związanych z leczeniem i procedurami oraz prowadzą pacjenta przez aspekty przeżycia35
  • Współpraca między akademickimi a społecznymi ośrodkami onkologicznymi jest ważna dla optymalizacji opieki nad pacjentami, zwłaszcza tymi z marginalizowanych populacji25

Usługi wspierające

Oprócz leczenia medycznego, pacjenci z AML potrzebują różnych usług wspierających:

  • Usługi wsparcia paliatywnego i hospicyjnego dla pacjentów z zaawansowaną chorobą36
  • Wsparcie żywieniowe i rehabilitacyjne dla poprawy jakości życia37
  • Wsparcie finansowe i pomoc w zarządzaniu kosztami opieki37
  • Wsparcie psychologiczne i emocjonalne dla pacjenta i jego rodziny38

Oczekiwane wyniki opieki pielęgniarskiej

Skuteczna opieka pielęgniarska powinna prowadzić do konkretnych, mierzalnych wyników u pacjentów z AML:

  • Pacjent pozostanie wolny od powikłań infekcyjnych i krwotocznych26
  • Zmęczenie będzie skutecznie zarządzane poprzez odpowiednie interwencje26
  • Pacjent wykaże zrozumienie białaczki i jej leczenia, w tym potencjalnych skutków ubocznych26
  • Pacjent rozwinie strategie radzenia sobie z emocjonalnymi i fizycznymi wyzwaniami związanymi z białaczką26
  • Cele opieki pielęgniarskiej często są znane jako wyniki. Są to pożądane rezultaty interwencji pielęgniarskich, które powinny być osiągalne w określonym czasie39

Specjalistyczna opieka pielęgniarska w AML

Specjalistyczna opieka pielęgniarska jest niezbędna dla zapewnienia najlepszej możliwej opieki pacjentom z AML.

Opieka szpitalna

Pacjenci z AML często wymagają hospitalizacji podczas leczenia, szczególnie podczas intensywnej chemioterapii:

  • Stosunek liczby pielęgniarek do pacjentów w St. Jude wynosi około 1:3 w hematologii i onkologii oraz 1:1 na oddziale intensywnej terapii40
  • Pacjenci z AML zazwyczaj pozostają w szpitalu przez cztery do pięciu tygodni podczas terapii indukcyjnej21
  • Po przeszczepie szpiku kostnego pacjenci muszą pozostać w szpitalu przez kilka tygodni, zwykle w osobnym pokoju, ze względu na wysokie ryzyko infekcji31

Opieka ambulatoryjna

Opieka ambulatoryjna jest ważnym aspektem długoterminowego zarządzania AML:

  • Dążymy do realizacji jak największej części opieki w trybie ambulatoryjnym. Jeśli hospitalizacja jest konieczna, nasz wykwalifikowany personel jest specjalnie przeszkolony do opieki nad pacjentami na każdym etapie podróży leczniczej41
  • Zachęcanie opiekunów do zapewnienia wsparcia emocjonalnego i pomocy w codziennych potrzebach pacjenta, w tym transportu na leczenie i zapewnienia przestrzegania zaleceń dotyczących leków26
  • Monitorowanie pacjentów po zakończeniu leczenia, zgodnie z wytycznymi zalecającymi specyficzne dla wieku i płci badania przesiewowe w kierunku nowotworów, rutynowe badania morfologii krwi w celu monitorowania nawrotu lub wystąpienia późniejszych nowotworów hematologicznych42

Specjalistyczne protokoły pielęgniarskie

Pielęgniarki stosują specjalistyczne protokoły w opiece nad pacjentami z AML:

  • Monitorowanie oznak i objawów infekcji i krwawienia43
  • Wdrażanie środków izolacji i promowanie higieny w celu zapobiegania infekcjom43
  • Podawanie leków, produktów krwiopochodnych i czynników stymulujących kolonie zgodnie z zaleceniami w celu leczenia białaczki i ochrony przed powikłaniami43
  • U pacjentów z gorączką neutropeniczną (mniej niż 500 neutrofili na μL [0,5 × 10^9 na L]) należy przeprowadzić ocenę źródła infekcji i rozpocząć empiryczną antybiotykoterapię o szerokim spektrum działania, taką jak imipenem/cilastatyna (Primaxin), meropenem (Merrem), piperacylina/tazobaktam (Zosyn) lub cefepim44

Zaawansowane kompetencje pielęgniarskie w opiece nad pacjentem z AML

Pielęgniarki opiekujące się pacjentami z AML powinny posiadać zaawansowane kompetencje w kilku obszarach:

Praktyka oparta na dowodach

Stosowanie praktyk opartych na dowodach naukowych jest kluczowe dla zapewnienia najlepszej opieki:

  • Zastosowanie opartego na dowodach wyboru leczenia dla pacjentów niekwalifikujących się do przeszczepu w remisji po terapii indukcyjnej25
  • Optymalizacja wyników dla pacjentów niekwalifikujących się do przeszczepu w środowisku społecznym25
  • Przegląd podejść do poprawy przestrzegania leczenia doustnymi lekami onkologicznymi25
  • Wdrażanie strategii optymalnego zarządzania działaniami niepożądanymi związanymi z leczeniem25

Kształcenie ustawiczne

Ciągłe doskonalenie zawodowe jest niezbędne dla pielęgniarek pracujących z pacjentami z AML:

  • Działalność przeznaczona dla pielęgniarek/praktyków hematologii/onkologii i asystentów lekarza45
  • Celem tej działalności jest lepsze leczenie i zarządzanie AML w celu optymalizacji jakości życia pacjentów45
  • Zwiększenie kompetencji związanych z zarządzaniem działaniami niepożądanymi leczenia u pacjentów z AML45
  • Wykazanie większej pewności w edukacji pacjentów na temat leczenia AML45

Rzecznictwo pacjenta

Pielęgniarki odgrywają kluczową rolę jako rzecznicy pacjentów z AML:

  • Identyfikacja i rozwiązywanie barier w opiece i leczeniu, szczególnie dla pacjentów z marginalizowanych populacji46
  • Zwiększanie świadomości na temat dostępnych opcji leczenia i badań klinicznych47
  • Wspieranie pacjentów w podejmowaniu świadomych decyzji dotyczących ich opieki48
  • Zapewnienie, że leczenie jest dostosowane do indywidualnych potrzeb i preferencji pacjenta49

Podsumowanie roli pielęgniarki w opiece nad pacjentem z AML

Pielęgniarki odgrywają kluczową rolę w opiece nad pacjentami z ostrą białaczką szpikową, zapewniając kompleksową opiekę, edukację i wsparcie przez cały proces leczenia. Ich zaangażowanie obejmuje ocenę pacjenta, planowanie opieki, wdrażanie interwencji, edukację pacjenta i rodziny oraz ewaluację wyników leczenia50.

Pielęgniarki muszą posiadać specjalistyczną wiedzę i umiejętności w zakresie zapobiegania infekcjom, zarządzania skutkami ubocznymi chemioterapii, monitorowania pacjenta pod kątem powikłań i zapewnienia wsparcia emocjonalnego. Ponadto, pielęgniarki współpracują z wielodyscyplinarnym zespołem w celu koordynacji opieki i zapewnienia najlepszych możliwych wyników dla pacjentów10.

Pomimo postępów w leczeniu, AML pozostaje poważnym wyzwaniem, wymagającym spersonalizowanego podejścia do każdego pacjenta. Pielęgniarki, dzięki swojej unikalnej pozycji w zespole opieki zdrowotnej, mają możliwość znaczącego wpływu na jakość życia i wyniki leczenia pacjentów z AML8.

Kolejne rozdziały

Zapraszamy do dalszego czytania naszego leksykonu.

Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.

  1. 13.04.2026
  2. www.leksykon.com.pl

Materiały źródłowe

  • #1 Acute Myeloid Leukemia (Nursing) – StatPearls – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK568718/
    Acute myeloid leukemia (AML) is the most common leukemia among the adult population and accounts for about 80% of all cases. […] Nursing Diagnosis: Anorexia, Fatigue, malaise, Weakness, Bruising, Bone pain, Fever, Frequent infections, Nose bleeds. […] Due to ineffective erythropoiesis and bone marrow failure, patients experience a variety of symptoms including recurrent infections, anemia, easy bruising, excessive bleeding, headaches, and bone pains. […] AML should be suspected in anyone with unexplained cytopenias (decreased cell count of white blood cells, hemoglobin or platelets), the presence of circulating blast cells in the peripheral blood, easy bruising or bleeding or recurrent infections. […] Individuals who achieve complete remission (CR) with a blast count of less than 5% in the bone marrow after induction therapy tend to have increased survival.
  • #2 Acute Myeloid Leukemia (Nursing) – StatPearls – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/sites/books/NBK568718/
    Acute myeloid leukemia (AML) is the most common leukemia among the adult population and accounts for about 80% of all cases. […] The oncology nurse is vital for treatment administration and monitoring for potential complications. […] The nurse should educate the patient on infection prevention by washing hands, rinsing all fruits and vegetables, avoiding crowds and seeking help at the first sign of fever. […] Nursing Management includes checking labs for coagulation parameters, checking vitals, providing skin protection, monitoring for infection and sepsis, promoting normothermia, educating the patient and family, monitoring ins and outs, checking if nutrition is sufficient, promoting hand washing, and encouraging self-care. […] Coordination of Care states that AML is a common hematological malignancy in adults. Despite many advances, the malignancy still carries a poor prognosis. Hence, it is best managed by a multidisciplinary team that includes a hematologist, oncologist, internist, pathologist, and an intensivist. […] The primary care physician should educate the patient on personal hygiene, hand washing, and immunization.
  • #3 Leukemia: Nursing Diagnoses, Care Plans, Assessment & Interventions | NurseTogether
    https://www.nursetogether.com/leukemia-nursing-diagnosis-care-plan/
    Leukemia is classified according to the rate at which the condition progresses and whether the leukemia cells come from lymphoid or myeloid cells. […] Acute Myelogenous Leukemia (AML) is the most common acute form in adults and is characterized by uncontrolled proliferation of myeloblasts and hyperplasia of the bone marrow. Clinical manifestations include fatigue, weakness, mouth sores, headache, bleeding, fever, anemia, and gingival hyperplasia. […] Nurses support patients with leukemia by providing supportive care, especially for those who are undergoing chemotherapy, radiation, and other biologic therapies. It is essential to manage and prevent complications, provide comfort measures, patient and family education, and continuous emotional support. […] Nursing interventions and care are essential for the patients recovery.
  • #4 Acute Myeloid Leukemia (Discharge Care)
    https://www.drugs.com/cg/acute-myeloid-leukemia-discharge-care.html
    Acute myeloid leukemia (AML) is also called acute myelogenous leukemia. It is a fast-growing cancer of the bone marrow and blood cells. Cells that should become white blood cells (WBCs) do not fully grow. These cells are called myeloblasts and monoblasts. They do not fight infection like a normal WBC should. They crowd the bone marrow and prevent normal blood cells from growing and fighting infection. […] Chemotherapy must be taken exactly as directed by your healthcare provider. […] Antibiotics fight or prevent infection caused by bacteria. Take your antibiotics until they are gone, even if you feel better sooner. […] Wash your hands often. Wash especially after you change a diaper or go to the bathroom. Wash your hands before you prepare food or eat. […] Avoid people who are sick. Your WBC’s will not be able to help your body fight infections. Stay away from people who have a cold or the flu. Also try to stay away from large groups of people to decrease your risk of getting a cold or flu.
  • #5 [On-Demand Video] Acute Myelogenous Leukemia: Treatment Updates and Implications for Older Patients – Carevive – cancer care management & patient engagement tools
    https://www.carevive.com/on-demand-video-acute-myelogenous-leukemia-treatment-updates-and-implications-for-older-patients/
    Acute myeloid leukemia (AML) is a disease of older adults, with a median age of presentation of 67 years; only 5-10% of patients are alive at 5 years. […] Traditionally older patients have not received intensive induction chemotherapy to avoid toxicities, yet current research shows fit patients treated with intensive chemotherapy have better outcomes than patients with no treatment. […] The goal of this program is to close existing cancer clinician competency gaps regarding new data on investigational agents for AML along with evolving evidence-based guidelines and current understanding of treatment outcomes among older patients with AML. […] Hematology care teams will receive updates on current treatment treatments, the new data on investigational agents for AML, and how to make risk-based decisions among older patients with AML. […] Recognize new data regarding the screening and management of older patients with AML. […] Employ an electronic screening tool in clinic to evaluate frailty status among older patients newly diagnosed AML or those needing a new line of therapy.
  • #6 A Nurse-Led Palliative and Supportive Care Intervention for Newly Diagnosed Adults with Acute Myeloid Leukemia | UNC School of Nursing
    https://nursing.unc.edu/projects/a-nurse-led-palliative-and-supportive-care-intervention-for-newly-diagnosed-adults-with-acute-myeloid-leukemia
    Acute Myeloid Leukemia (AML) is a disease of older adults, with a median age at diagnosis of sixty eight and five-year survival rate of 28%. […] After diagnosis, adults with AML depend on their caregivers for support and care from home, but often caregivers lack the knowledge and skill required to manage the older adults serious illness. […] This funding will be used to plan and develop a nurse- led palliative and collaborative care (PACT) study, which will prepare caregivers to deliver palliative and supportive care, ultimately increasing patients chances of returning home after treatment and leading to better quality of life.
  • #7 Acute Myeloid Leukemia (AML) > Fact Sheets > Yale Medicine
    https://www.yalemedicine.org/conditions/acute-myeloid-leukemia-aml
    The outlook for people who have AML depends on several factors, including the patients age, general health, and whether they have previously been treated with chemotherapy for another medical condition. […] The five-year survival rate for adults with AML in the U.S. is 29.5%. For children and adolescents aged 19 or younger, the five-year survival rate is 66%. […] When someone is either diagnosed with or has a concern for AML, they are seen by an AML specialist who performs a thorough evaluation in conjunction with other members of our team comprised not only of physicians, but also of advanced practice providers, nurses, social workers, nutritionists, and clinical trial staff, among others.
  • #8 Acute Myeloid Leukemia (AML) > Fact Sheets > Yale Medicine
    https://www.yalemedicine.org/conditions/acute-myeloid-leukemia-aml
    Acute myeloid leukemia (AML) is the most common type of acute leukemia in adults. […] In people with AML, symptoms usually develop and progress rapidly over the course of a few weeks. Because it is an aggressive cancer, treatment should start as soon as it is diagnosed. […] Many patients with AML have the prospect of cure, but this is a heterogeneous disease for which the treatments and patient journey can vary greatly. […] The low blood counts that can come with AML and the treatments directed against it are addressed with blood product transfusions, vigilance for infection prevention and treatment, and other layers of support to help patients realize the potential benefits of therapy. […] This is an encouraging time for the treatment of AML, for which many targeted therapies are now standards of care and many more are in development with promising initial results.
  • #9 Leukemia: Nursing Diagnosis & Interventions | Nurse.com
    https://www.nurse.com/clinical-guides/leukemia/?srsltid=AfmBOorDqlP42vezZRi0gHBNR6UAwzqMCo7kJmV4SqFpdxiz77N4Vkpp
    Leukemia patients often experience fatigue, infection risk, bleeding, and emotional distress. Nurses must focus on managing these symptoms and providing education and support throughout the treatment process. […] Monitor CBC and differential: Watch for signs of increased risk for infection (neutropenia), anemia, and thrombocytopenia. […] Evaluate for signs of infection: Fever, chills, and any new symptoms should be reported immediately, as leukemia patients are immunocompromised. […] Assess bleeding: Look for petechiae, bruising, and bleeding gums, particularly in thrombocytopenic patients. […] Psychosocial assessment: Determine the patients coping mechanisms, support system, and need for psychological support. […] Risk for infection related to leukopenia and immunosuppressive treatments
  • #10 8 Leukemia Nursing Care Plans – Nurseslabs
    https://nurseslabs.com/leukemia-nursing-care-plans/
    The nursing management and care plan for patients with leukemia involve several important aspects. Nurses play a crucial role in assessing and monitoring patients, managing symptoms, and providing support throughout the treatment journey. […] The following are the nursing priorities for patients with leukemia: Minimizing infection through infection control, Managing side effects of chemotherapy, Managing pain, Providing emotional support, Providing health teachings. […] Clients with leukemia are at risk for infection due to the diseases impact on the bone marrow and immune system. Leukemia disrupts the production of normal blood cells, including white blood cells that play a crucial role in fighting infections, leaving the body vulnerable to bacterial, fungal, and viral infections. […] Infection prevention strategies are essential in reducing the risk of complications and ensuring optimal treatment outcomes.
  • #11 Leukemia, Acute Nursing Care Plan & Management – RNpedia
    https://www.rnpedia.com/nursing-notes/medical-surgical-nursing-notes/leukemia-acute/
    The most accurate nursing diagnosis for a patient with acute lymphocytic leukemia (ALL) and thrombocytopenia (low platelet count) is Risk for injury. […] The most appropriate room placement for Mrs. Davis, who has thrombocytopenia and is undergoing treatment for acute lymphocytic leukemia (ALL), is a private room to protect her from infections that could be brought in by others.
  • #12 Leukemia, Acute Nursing Care Plan & Management – RNpedia
    https://www.rnpedia.com/nursing-notes/medical-surgical-nursing-notes/leukemia-acute/
    There are two major forms of acute leukemia: lymphocytic leukemia and nonlymphocytic leukemia. […] Acute myelogenous leukemia (AML) (also known as acute nonlymphocytic leukemia, or ANLL) causes the rapid accumulation of megakaryocytes (precursors to platelets), monocytes, granulocytes, and RBCs. […] Risk for infection related to decreased primary and secondary responses […] INTERVENTIONS. Infection control; Infection protection; Surveillance; Fluid/electrolyte management; Medication management; Temperature regulation […] Acute myelogenous leukemia (AML) drugs include daunorubicin, idarubicin, cytosine arabinoside, and mitoxantrone. […] The treatment for acute leukemia occurs in four phases: induction, consolidation, continuation, and treatment of (CNS) leukemia. […] The primary nursing diagnosis for a client with acute leukemia is Risk for injury related to thrombocytopenia, as this condition places the patient at high risk for bleeding.
  • #13 Leukemia: Nursing Diagnosis & Interventions | Nurse.com
    https://www.nurse.com/clinical-guides/leukemia/?srsltid=AfmBOorDqlP42vezZRi0gHBNR6UAwzqMCo7kJmV4SqFpdxiz77N4Vkpp
    Risk for bleeding related to thrombocytopenia and bone marrow suppression […] Fatigue related to anemia and the effects of chemotherapy […] Disturbed body image related to hair loss, weight loss, and pallor from leukemia treatment. […] Infection prevention: Implement neutropenic precautions, such as hand hygiene, limiting visitors, and avoiding exposure to infectious agents. […] Bleeding precautions: Educate the patient on avoiding activities that may lead to injury, using soft toothbrushes, and avoiding over-the-counter medications like aspirin. […] Supportive care: Provide energy-conserving strategies for managing fatigue, such as frequent rest periods and small, nutrient-dense meals. […] Emotional support: Offer counseling services and encourage participation in leukemia support groups. Assist patients with coping strategies and body image issues, including hair loss management.
  • #14 8 Leukemia Nursing Care Plans – Nurseslabs
    https://nurseslabs.com/leukemia-nursing-care-plans/
    Clients with leukemia are at risk for deficient fluid volume due to several factors, including excessive losses through vomiting, diarrhea, or bleeding, decreased fluid intake due to poor appetite, and increased fluid needs resulting from fever or chemotherapy. […] These factors can lead to dehydration, electrolyte imbalances, and other complications, making it essential to monitor and maintain fluid balance in these clients. […] Effective pain management is essential to alleviate suffering, enhance quality of life, and promote patient comfort. Nursing interventions play a pivotal role in managing acute pain in these patients. […] Health teachings and patient education empower individuals to make informed decisions, manage treatment-related symptoms, and adopt healthy lifestyle practices.
  • #15 Acute Myeloid Leukemia (Nursing) – StatPearls – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK568718/
    The induction therapy is highly toxic to bone marrow causing pancytopenias and bleeding complications, gastrointestinal system issues, kidney failure due to tumor lysis syndrome, and electrolyte disturbances. […] After achieving CR with induction therapy, consolidation therapy is initiated with high dose cytarabine, called HiDAC and hematopoietic cell transplantation (HCT). […] The oncology nurse is vital for treatment administration and monitoring for potential complications. […] The nurse should educate the patient on infection prevention by washing hands, rinsing all fruits and vegetables, avoiding crowds and seeking help at the first sign of fever.
  • #16 Leukemia: Nursing Diagnoses, Care Plans, Assessment & Interventions | NurseTogether
    https://www.nursetogether.com/leukemia-nursing-diagnosis-care-plan/
    The healthcare team will decide on the best treatment options depending on the following: The patients current health status, The type of leukemia, The presence of metastasis to other parts of the body. […] Chemotherapy is necessary to eradicate cancer cells. […] Immunotherapy (biologic therapy) strengthens the bodys immune system to fight leukemia. […] Targeted therapy involves drugs created to target particular components of a leukemia cell (such as a protein or gene) causing the abnormality. […] Patients with leukemia are at risk for developing infections as they have a low white blood cell count and a compromised immune system. […] Administer antibiotics as ordered. Antibiotics may be provided prophylactically to prevent infections, especially if undergoing an invasive procedure. […] Providing adequate nutrition can help enhance the patients immune system, reducing the risk of infection.
  • #17 Acute Myeloid Leukemia (Discharge Care)
    https://www.drugs.com/cg/acute-myeloid-leukemia-discharge-care.html
    Do not use sharp objects. Use an electric razor to shave. Use a nail file to keep your nails short and smooth. […] Care for your mouth. Use a soft toothbrush. Do not floss your teeth while your platelet count is low. Do not use toothpicks. […] You will need to see your oncologist for ongoing treatment. Write down your questions so you remember to ask them during your visits. […] Alcohol can thin your blood and make it easier to bleed. Smoking increases your risk for new or returning cancer. Smoking can also delay healing after treatment. […] High-fiber foods, extra liquids, and regular exercise can help you prevent constipation. […] Eating healthy foods may help you feel better and have more energy. […] For most people, healthy liquids to drink are water, juices, and milk.
  • #18 Acute Myeloid Leukemia (AML) Treatment & Management: Approach Considerations, Treatment of Acute Myeloid Leukemia, Treatment of Acute Promyelocytic Leukemia
    https://emedicine.medscape.com/article/197802-treatment
    Treatment options for acute myeloid leukemia (AML) comprise a variety of chemotherapy regimens, biologic agents, and stem cell transplantation. […] Current standard chemotherapy regimens cure only a minority of patients with AML. As a result, all patients should be evaluated for entry into well-designed clinical trials. […] When receiving chemotherapy, patients should avoid exposure to crowds and people with contagious illnesses, especially children with viral infections. […] Appropriate transfusion support must be provided to patients with AML. This includes transfusion of platelets and clotting factors (fresh frozen plasma [FFP], cryoprecipitate) as guided by the patients blood test results and bleeding history. […] Patients with AML are best treated at a center whose staff has significant experience in the treatment of leukemia.
  • #19 8 Leukemia Nursing Care Plans – Nurseslabs
    https://nurseslabs.com/leukemia-nursing-care-plans/
    Nurses play a crucial role in administering medications, monitoring their effectiveness and side effects, and providing education and support to patients and their families. […] Regular monitoring of laboratory parameters and diagnostic procedures provides valuable information for treatment planning and management.
  • #20 Acute myelogenous leukemia – Diagnosis and treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/acute-myelogenous-leukemia/diagnosis-treatment/drc-20369115
    Acute myelogenous leukemia care at Mayo Clinic […] Our caring team of Mayo Clinic experts can help you with your acute myelogenous leukemia-related health concerns […] Many types of treatment exist for acute myelogenous leukemia, also called AML. Treatment depends on several factors, including the subtype of the disease, your age, your overall health, your prognosis and your preferences. […] Treatment usually has two phases: Remission induction therapy. This first phase aims to kill the leukemia cells in your blood and bone marrow. But it doesn’t usually destroy all the leukemia cells. You will need further treatment to keep the disease from coming back. […] Consolidation therapy. This phase also is called post-remission therapy or maintenance therapy. It aims to kill the remaining leukemia cells. Consolidation therapy is crucial to helping lower the risk of relapse.
  • #21 Acute Myeloid Leukemia | Conditions | UCSF Health
    https://www.ucsfhealth.org/conditions/acute-myeloid-leukemia
    Because AML can progress rapidly, it’s important to start treatment as soon as possible. The specific treatment plan depends on the patient’s age, overall health and results of their cytogenetic testing. For most patients under 70, the treatment goal is to cure their AML. […] Induction chemotherapy uses anticancer drugs to destroy as many cancer cells as possible. The goal is remission, which is when no leukemia cells are detectable in the blood or bone marrow and the body maintains normal numbers of blood cells without the need for transfusions. […] Our skilled and experienced team will monitor and care for you throughout this process. They may give you transfusions of red blood cells and platelets to correct anemia and prevent bleeding. […] Most patients are in the hospital for four to five weeks. You’ll be discharged once your blood counts have returned to normal and your bowels are functioning properly. At the end of your induction therapy, you’ll have a bone marrow biopsy to see whether your AML is in remission. Approximately 70 to 80% of patients enter complete remission after this first phase of treatment.
  • #22 Acute Myelogenous Leukemia
    https://www.rwjbh.org/treatment-care/cancer/types-of-cancer/blood-cancer/acute-myelogenous-leukemia-aml-/
    Acute myelogenous leukemia treatment can be divided into two phases: Remission induction therapy. The goal during this phase is to kill leukemia cells. […] Consolidation therapy. The goal during this phase is to kill the remaining leukemia cells. […] Treatment options used during each phase may include: Chemotherapy. Chemicals are used to kill cancer cells. […] Targeted therapy. Drugs are used to block receptors that cancer cells need to grow. […] Stem cell transplant. This may be performed in the consolidation phase. […] Although it is a serious disease, acute myelogenous leukemia can be curable with the right modern treatment options.
  • #23 Acute Myeloid Leukemia | Conditions | UCSF Health
    https://www.ucsfhealth.org/conditions/acute-myeloid-leukemia
    This treatment phase aims to destroy any remaining abnormal cells that may not be active but could cause a recurrence of the cancer. Treatment entails additional cycles of intensive chemotherapy and, in some cases, a bone marrow transplant (BMT), also known as a stem cell transplant. […] The treatment plan is different for patients who have the type of AML called acute promyelocytic leukemia (APL). Therapy for APL includes a vitamin A derivative called all-trans retinoic acid (ATRA) and arsenic trioxide, together with standard chemotherapy drugs. Most people undergo multiple cycles of this therapy. APL patients rarely need a stem cell transplant. Because of advances in diagnosis and treatment, APL is now considered the most curable form of acute myeloid leukemia.
  • #24 Acute myelogenous leukemia – Diagnosis and treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/acute-myelogenous-leukemia/diagnosis-treatment/drc-20369115
    A bone marrow transplant, also called a bone marrow stem cell transplant, involves putting healthy bone marrow stem cells into the body. These cells replace cells hurt by chemotherapy and other treatments. A bone marrow stem cell transplant may be used for both remission induction and consolidation therapy. […] Before a bone marrow transplant, you receive very high doses of chemotherapy or radiation therapy to destroy your leukemia-producing bone marrow. Then you receive infusions of stem cells from a compatible donor. This is called an allogeneic transplant. […] There is an increased risk of infection after a transplant. […] Some people with leukemia choose to enroll in clinical trials to try experimental treatments or new combinations of known therapies. […] No alternative treatments have been found to treat acute myelogenous leukemia. But integrative medicine may help you cope with the stress of a cancer diagnosis and side effects of your treatment.
  • #25
    https://www.accc-cancer.org/home/learn/cancer-types/hematologic-malignancies/achieving-maintaining-better-outcomes-for-patients-with-acute-myeloid-leukemia-project
    Apply evidence-based treatment selection for transplant-ineligible patients in remission following induction therapy […] Optimize outcomes for transplant-ineligible patients in the community setting […] Review approaches to improve oral oncolytic treatment adherence […] Employ strategies for the optimal management of treatment-related adverse events […] Implement solutions for improving care coordination between academic and community cancer centers to enable optimal management of patients, especially those from marginalized populations. […] Maintenance therapy for patients with acute myeloid leukemia, particularly those who are ineligible for transplant, can be critical to treatment outcomes and quality of life for patients. […] Coordination of care for patients diagnosed with acute myeloid leukemia, particularly those who are ineligible for transplant, can impact access to specialist care, clinical trials, and cancer programs with advanced capabilities to treat patients with acute myeloid leukemia.
  • #26 Leukemia: Nursing Diagnosis & Interventions | Nurse.com
    https://www.nurse.com/clinical-guides/leukemia/?srsltid=AfmBOorDqlP42vezZRi0gHBNR6UAwzqMCo7kJmV4SqFpdxiz77N4Vkpp
    Patient will remain free of infection and bleeding complications […] Fatigue will be managed effectively with appropriate interventions […] Patient will demonstrate understanding of leukemia and its treatment, including potential side effects […] Patient will develop coping strategies to manage the emotional and physical challenges of leukemia. […] Educate the patient and family about the importance of infection prevention and how to recognize signs of infection, such as fever. […] Discuss potential side effects of chemotherapy and targeted therapies, including nausea, hair loss, and increased risk of bleeding. […] Provide information about stem cell transplantation, if applicable, including the process and potential complications. […] Encourage caregivers to provide emotional support and help manage the patients day-to-day needs, including transportation to treatments and ensuring medication adherence.
  • #27 Acute Myeloid Leukemia – What You Need to Know
    https://www.drugs.com/cg/acute-myeloid-leukemia.html
    Acute myeloid leukemia (AML) is also called acute myelogenous leukemia. It is a fast-growing cancer of the bone marrow and blood cells. […] You may have treatment in phases. In the first phase (induction phase), healthcare providers will give you treatments to make your AML go into remission. Remission means there are no longer any signs of leukemia. After you are in remission, you will receive the next phase of treatment called postremission treatment. The goal of this phase it to kill any hidden leukemia cells and help you stay in remission. […] Prevent infection. Wash your hands often, avoid people who are sick, and clean humidifiers daily. Ask your healthcare provider for more information on preventing infection. […] Prevent bleeding and bruising. Be careful with sharp or pointed objects, such as knives and toothpicks. Do not play contact sports, such as football. Use a soft toothbrush. Do not floss your teeth while your platelet count is low.
  • #28 Acute Myeloid Leukemia – What You Need to Know
    https://www.drugs.com/cg/acute-myeloid-leukemia.html
    Drink liquids as directed. You may need to drink extra liquids to prevent dehydration, especially if you are vomiting or have diarrhea from cancer treatments. […] Exercise as directed. AML or its treatment may make you feel tired. Exercise can help you have more energy. Exercise can also help you manage your weight. […] Eat healthy foods. Healthy foods may help you feel better and have more energy. If you have trouble swallowing, you may be given foods that are soft or in liquid form. Ask about any extra nutrition you may need, such as nutrition shakes or vitamins.
  • #29
    https://myhealth.alberta.ca/Health/aftercareinformation/pages/conditions.aspx?hwid=uf8953
    Acute myeloid leukemia (AML) is a cancer of the blood cells. It is also called acute myelogenous leukemia. […] Follow-up care is a key part of your treatment and safety. Be sure to make and go to all appointments, and call your doctor or nurse advice line (811 in most provinces and territories) if you are having problems. […] Take your medicines exactly as prescribed. Call your doctor or nurse advice line if you think you are having a problem with your medicine. […] If you have not already done so, prepare an advance care plan. An advance care plan provides instructions to your doctor and family members about what kind of care you want if you become unable to speak or express yourself. […] Call your doctor or nurse advice line now or seek immediate medical care if: You have a fever or chills. Or you may be sweating. […] Watch closely for changes in your health, and be sure to contact your doctor or nurse advice line if: You are much more tired than usual. You have swollen glands in your armpits, groin, or neck. You do not get better as expected.
  • #30 Acute Myeloid Leukemia (AML) – Together by St. Jude™
    https://together.stjude.org/en-us/conditions/cancers/acute-myeloid-leukemia-aml.html
    Acute myeloid leukemia (AML) is a cancer of the blood and bone marrow. […] Treatment may include chemotherapy and stem cell transplant (bone marrow transplant). […] Chemotherapy is the most common AML treatment. Stem cell transplant (also called bone marrow transplant or hematopoietic cell transplant) may also be an option. […] The consolidation phase starts after the patient is in remission. The goal of this phase is to destroy any leukemia cells that remain. […] Cancer patients should continue to see their treatment center care team and/or a local primary care provider after cancer treatment.
  • #31
    https://www.nhs.uk/conditions/acute-myeloid-leukaemia/treatment/
    If the treatment is not working or there’s a high chance of your leukaemia coming back, you may be offered a bone marrow or stem cell transplant. […] You’ll need to stay in hospital for a few weeks after the transplant, usually in a room on your own, because you’ll have a high chance of getting infections. […] A treatment team for AML may include a: haematologist (blood cancer specialist) […] cancer nurse specialist (sometimes called a CNS), who will be the first point of contact between you and the members of your care team.
  • #32 Leukemia Treatment & Diagnosis | University of Kansas Cancer Center
    https://www.kucancercenter.org/cancer/cancer-types/leukemia
    Each person is unique, so we tailor your care to your personal needs. This means doctors, nurses and other staff work closely together. They discuss every person’s leukemia diagnosis and treatment as a team to stay up to date on your care and treatment. […] AML is really a rare cancer, and so it’s important for patients to be treated at a center that actually specializes in AML. […] Our pharmacists here at the University of Kansas Cancer Center specialize in leukemia, in those chemotherapy drugs, what those toxicities are. Our nurses specialize in taking care of patients who are getting this kind of chemotherapy. […] By being part of an academic medical center and being part of an NCI designated cancer center, we really have access to the most innovative and cutting edge clinical trials.
  • #33 Leukemia Treatment & Diagnosis | University of Kansas Cancer Center
    https://www.kucancercenter.org/cancer/cancer-types/leukemia
    Our goal was really to develop a comprehensive program, and our goal is to have a clinical trial for every patient. […] The key to identifying and getting patients quickly to transplant who are really gonna benefit from it is early access and early referrals. […] We want to have trials for patients who are going on to stem cell transplants, trials for patients to get additional treatment after their stem cell transplant. […] We have developed a 141 gene panel that we run in house. […] If our disease is so different than it was 40 years ago, we have all of these new treatments, the key is to be able to figure out which patient matches with which new treatment, which patient matches with which kind of clinical trial, based on those profiles. […] We know so much more about leukemia biology and we have so many new drugs and strategies at our disposal. That is only gonna continue to grow as we learn more and conduct clinical trials, to be able to bring those exciting laboratory discoveries right to our patients.
  • #34 Acute Myeloid Leukemia | Fred Hutchinson Cancer Center
    https://www.fredhutch.org/en/diseases/acute-myeloid-leukemia.html
    At Fred Hutch, we surround you with experts who focus completely on cancer. A handful of people make up the core of your care team. You will have a hematologist-oncologist and a registered nurse who specialize in AML. […] The safest, most effective and most widely accepted therapies for cancer are known as the standard of care. For many patients, these therapies will be a large part of their treatment. At Fred Hutch, we provide all standard therapies for AML. […] Along with treating your cancer, a group of world-class professionals is here to support you. This team includes advanced practice providers, pharmacists, nurses, dietitians, physical therapists, social workers and psychologists. We also include supportive care services for your physical, mental and emotional well-being. […] At Fred Hutch, caregivers are valuable members of a patients care team. We see every day that your presence and support make a difference. We know that what your friend or family member is going through affects you, too. […] When your care team designs your treatment plan, they will give you the choice to join clinical trials that match your situation. If you decide to join one, you will see the same physicians and nurses as you would for standard therapy.
  • #35 Acute Myelogenous Leukemia
    https://www.rwjbh.org/treatment-care/cancer/types-of-cancer/blood-cancer/acute-myelogenous-leukemia-aml-/
    Acute myelogenous leukemia (AML) is a form of cancer that develops in the blood cells of the bone marrow. […] As the leukemia cells grow, they can crowd out the normal cells in the bone marrow. This inhibits the diversity of blood cells and decreases red blood cell counts. […] AML tends to grow fast and needs to be treated right away. […] We are New Jerseys largest network of cancer specialists, including nationally and internationally recognized hematologists/oncologists, radiation oncologists, advanced practice nurses and oncology support professionals with advanced credentials in cancer with expertise in blood cancers. […] Nurse navigators help secure appointments, coordinate follow-up visits related to treatments and procedures, and guide you through aspects of survivorship. […] A care plan for AML depends on: The type of acute myelogenous leukemia, Age, Overall health, Personal preferences.
  • #36 AML Late Stages: Spread, Symptoms & Care – HealthTree for Acute Myeloid Leukemia
    https://healthtree.org/aml/community/articles/aml-late-stages-symptoms-care
    The final stages of AML can also impact a patient’s mental health. Patients may experience symptoms of anxiety and depression. […] To receive support in alleviating pain or discomfort from AML, click here to learn about palliative care and hospice resources available to AML patients. […] The progression of AML itself can cause death due to multiple organ failure. Additionally, complications related to disease progression, such as infections, bleeding, and thrombotic events, such as heart attacks and strokes, may cause death. Treatment complications can also cause death in some patients. […] AML can progress rapidly and may spread to other areas of the body. […] As AML progresses, symptoms may worsen or change. […] AML can cause death due to organ failure, infection, bleeding, or thrombotic events.
  • #37 Acute Myeloid Leukemia: Treatment Options | UVA Health
    https://uvahealth.com/services/blood-cancer/acute-myeloid-leukemia
    It’s not just about medical experts. At UVA Health, we’re ready and available to support and care for you as a whole person. […] Our team of specialists will help you navigate what to eat and how to recover. You’ll get guidance on handling the cost of care and emotional challenges. We even have support for the people in your life caring for you.
  • #38 Acute Myeloid Leukemia, Blood Cancer, Information, Resources
    https://www.cancercare.org/diagnosis/acute_myeloid_leukemia
    Cancer Care provides free, professional support services for people affected by acute myeloid leukemia (AML), as well as AML treatment information and additional resources. […] Oncology social workers help you cope with the emotional and practical challenges of acute myeloid leukemia. […] Find resources and support to manage your financial concerns. Limited assistance from Cancer Care is available to eligible families for cancer-related costs. […] Connect with others in our free support groups led by oncology social workers. […] Cancer Care offers specialized programs to address specific populations and concerns. […] Read or order our free Connect booklets and fact sheets offering easy-to-read information about the latest cancer treatments, managing side effects and coping with cancer.
  • #39 Nursing care plan for acute myeloid leukemia
    https://nursipedia.com/nursing-care-plan-acute-myeloid-leukemia/
    The goals of nursing care are often known as outcomes. These are the desired results of nursing interventions which should be achievable within a set timeframe. For acute myeloid leukaemia, common outcomes include pain management, comfort promotion, enhanced physical activity, reduction in risk for bleeding and improved stress response. […] Interventions are the methods used by the nurse to achieve the desired outcomes. These may include medications, education, physical activities, psychosocial support, nutrition and lifestyle modifications. […] When planning interventions for nursing care, health practitioners must consider the rationale behind their decisions. Rationales explain why an intervention has been chosen and provide an indication of the expected outcome. When using interventions for the treatment of acute myeloid leukaemia, rationales should emphasise pain management, comfort promotion, reduced risks and improved quality of life.
  • #40 Acute Myeloid Leukemia (AML) Treatment | St. Jude Care & Treatment
    https://www.stjude.org/care-treatment/treatment/childhood-cancer/leukemia-lymphoma/acute-myeloid-leukemia-aml.html
    Acute myeloid leukemia care at St. Jude provides the highest quality of care for patients with AML: […] The nurse-to-patient ratio at St. Jude is about 1:3 in hematology and oncology and 1:1 in the Intensive Care Unit. […] St. Jude offers a dedicated team of specialists to meet the needs of children with cancer, including: Surgeons, doctors, and nurses who treat this cancer. […] Patients accepted to St. Jude must have a disease we treat and must be referred by a physician or other qualified medical professional.
  • #41 What is Acute Myeloid Leukemia (AML)? Symptoms, Risk Factors & Treatments | MD Anderson Cancer Center
    https://www.mdanderson.org/cancer-types/acute-myeloid-leukemia.html
    Whether you are treated as an inpatient or outpatient, our comprehensive program offers all the services needed to care for leukemia and respond to its impact on your body. We aim to accomplish as much care as possible on an outpatient basis. If hospitalization is needed, our expert staff is specially trained to care for patients at every phase of the treatment journey.
  • #42 Leukemia: An Overview for Primary Care | AAFP
    https://www.aafp.org/pubs/afp/issues/2014/0501/p731.html
    Survivors of leukemia have an increased risk of subsequent cancers, likely because of the cellular damage caused by chemotherapy or radiation. In the Childhood Cancer Survivor Study (a cohort of more than 17,000 childhood cancer survivors in North America treated between 1970 and 1986), the 30-year cumulative incidence of neoplasm after leukemia was 5.6%, and the median time to occurrence of the subsequent cancer was nine years. […] Guidelines recommend age- and sex-specific cancer screening, routine complete blood count to monitor for relapse or occurrence of a subsequent hematologic malignancy, and a low threshold for brain imaging for neurologic symptoms in patients who have received cranial or craniospinal irradiation.
  • #43 Nursing Care Plan AML | PDF | Leukemia | Chemotherapy
    https://www.scribd.com/doc/62062942/Nursing-Care-Plan-AML
    1. Monitor for signs and symptoms of infection and bleeding. 2. Implement isolation precautions and promote hygiene to prevent infection. 3. Administer medications, blood products, and colony stimulating factors as ordered to treat the leukemia and protect from complications. […] 1. Monitor for signs and symptoms of infection and bleeding. 2. Implement isolation precautions and promote hygiene to prevent infection. 3. Administer medications, blood products, and colony stimulating factors as ordered to treat the leukemia and protect from complications.
  • #44 Leukemia: An Overview for Primary Care | AAFP
    https://www.aafp.org/pubs/afp/issues/2014/0501/p731.html
    Acute myelogenous leukemia accounts for 80% of acute leukemia in adults. Adults also present with constitutional symptoms such as fever, fatigue, and weight loss. They may have anemia-related symptoms, such as shortness of breath or chest pain, or symptoms related to thrombocytopenia, such as excessive bruising, nosebleeds, or heavy menstrual periods in women. […] A patient with suspected leukemia should be referred to a hematologist-oncologist to confirm the diagnosis and initiate treatment. Treatment for acute leukemia may include chemotherapy, radiation, monoclonal antibodies, or hematopoietic stem cell transplantation. The type of treatment depends on the leukemia subtype, cytogenetic and molecular findings, patient age, and comorbid conditions. […] Immunosuppression from chemotherapy, hematopoietic stem cell transplantation, or the leukemia itself may increase the risk of serious infections. In patients with leukemia, fever with neutropenia (fewer than 500 neutrophils per L [0.5 109 per L]) should prompt an evaluation for infection source and the initiation of empiric broad-spectrum antibiotic therapy, such as imipenem/cilastatin (Primaxin), meropenem (Merrem), piperacillin/tazobactam (Zosyn), or cefepime.
  • #45 Patient-Focused Care: Nursing Pearls to Improve Outcomes in Acute Myeloid Leukemia and Myelodysplastic Syndromes
    https://www.medscape.org/viewarticle/974611
    This activity is intended for hematology/oncology nurse practitioners, nurses, and physician assistants. […] The goal of this activity is that learners will be better able to treat and manage AML and MDS to optimize quality of life for their patients. […] Have greater competence related to managing adverse events of treatment for patients with AML or MDS. […] Demonstrate greater confidence in their ability to educate patients about AML and MDS treatments.
  • #46
    https://www.accc-cancer.org/home/learn/cancer-types/hematologic-malignancies/achieving-maintaining-better-outcomes-for-patients-with-acute-myeloid-leukemia-project
    While there are many factors why patients with acute myeloid leukemia are ineligible for allogeneic stem cell transplant, such as age, financial hurdles, or other comorbidities, these factors are often compounded by social determinants of health, which can act as a significant barrier to consolidation therapy and long-term remission for these patients. […] Discover recommendations for cancer care providers to improve care quality and outcomes for patients with acute myeloid leukemia who do not receive a transplant. […] ACCC in partnership with HealthTree Foundation for Acute Myeloid Leukemia, has launched an education program to explore the current barriers in care coordination and therapy options for patients with AML who are not eligible for transplant.
  • #47 Acute Myelogenous Leukemia | NCCN Continuing Education
    https://education.nccn.org/category/disease-area/acute-myelogenous-leukemia
    Individualized patient care is highly important in acute myeloid leukemia (AML) therapy to ensure the most effective treatment regimens can be selected for appropriate patients. […] Maintenance therapy is an aspect of acute myeloid leukemia (AML) management that currently demonstrates strong promise in efforts to prolong survivability and improve overall survival. Given the forthcoming evidence in this area, it is highly important for health care professionals responsible for the care of patients with AML to be aware of both new treatment standards and emerging research in maintenance therapy options. […] As a result of the therapeutic advances and clinical research affecting the management of patients with leukemia, clinicians can benefit by comparing their individual skills of diagnosis, treatment, and management of patients with their peers. This peer interaction is an integral part in enhancing clinical decision-making skills that can improve patient care.
  • #48 Acute myelogenous leukemia – Diagnosis and treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/acute-myelogenous-leukemia/diagnosis-treatment/drc-20369115
    Acute myelogenous leukemia is a fast-growing cancer that requires quick decision-making. The following tips and resources may help you cope: Learn enough about acute myelogenous leukemia to make decisions about your care. […] You can waste a lot of time researching information that doesn’t apply to your kind of leukemia. To avoid that, ask your doctor to write down as many details as possible about your specific disease. Then narrow your search to that disease. […] Having a support system can help you cope. Get support from people close to you, a formal support group or others coping with cancer. […] It’s easy to get caught up in tests, treatments and procedures. But it’s important to take care of yourself, not just the cancer. Try to make time for cooking, watching sports or other favorite activities. […] Your healthcare professional is likely to ask you questions. Being ready to answer them may give you more time to go over other questions you have.
  • #49 Acute Myeloid Leukemia (AML) > Fact Sheets > Yale Medicine
    https://www.yalemedicine.org/conditions/acute-myeloid-leukemia-aml
    Treatment may also vary by subtype. Acute promyelocytic leukemia (APL), for instance, is a subtype of AML in which genes from one chromosome switch places with genes on another chromosome. […] Doctors determine the best course of treatment based on various factors, including the subtype of AML, as well as the patients age and general health. […] In general, though, treatment of AML is divided into two phases: Induction chemotherapy and Consolidation therapy. […] In addition to chemotherapy and stem cell transplantation, other treatments for AML may be used, including targeted therapy, which uses drugs designed to target specific components found in cancer cells but not healthy cells. […] Sometimes, AML does not respond well to treatment or comes back after a period of remission. […] Subtypes of AML may require a different course of treatment. APL, for example, is treated with drugs called differentiation agents.
  • #50 Nursing care plan for acute myeloid leukemia
    https://nursipedia.com/nursing-care-plan-acute-myeloid-leukemia/
    Evaluating the effectiveness of a nursing care plan is essential. Regular assessments should be carried out to evaluate the patients progress and any changes that have occurred during care. Evaluation will help to ensure that any adverse effects are minimised and that the patient is receiving the best possible care. […] A comprehensive nursing care plan is essential for the successful treatment of acute myeloid leukaemia. By assessing the patients physical, psychological and emotional needs, nurses can identify problems and develop an appropriate plan of care. This plan should include interventions that are based on evidence-based practice and should be evaluated regularly to ensure that treatment is effective and beneficial for the patient. Overall, a comprehensive nursing care plan ensures that the patients needs are being met and that their care is optimal.